萬隆控股集團(00030.HK)擬攜手深圳麥爾美於日本消費及煙草市場合作開發CBD相關終端產品
格隆匯1月19日丨萬隆控股集團(00030.HK)公吿,公司與深圳市麥爾美健康科技有限公司("深圳麥爾美",一間於中國註冊成立有限責任公司,為獨立第三方)已訂立一項不具法律約束力諒解備忘錄,以於日本消費及煙草市場合作開發CBD相關終端產品。
為配合擴張,並充分發揮雲南白藥集團股份有限公司的研究能力及行業知識, 集團於2022年1月10日成立一間新的附屬公司-萬麻科技雲南有限公司。
萬麻科技總部設於中國雲南自由貿易試驗區昆明片區經開區國際工業大麻產業園。萬麻科技主要從事工業大麻的開發、種植及國際營銷,其成立預計將在促進本集團縱向擴展至大麻種植及擴張方面發揮關鍵作用,其長遠願景是讓本集團成為高端健康產品市場的主要參與者。
通過整合雲南白藥集團在中國市場的知識及經驗以及集團與香港這個國際貿易及金融中心的聯繫,亦已產生協同效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.